These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7623602)

  • 21. Effects of quetiapine on executive functioning deficits in schizophrenia: short-term effect.
    Mendoza Quiñones R; Cabral Calderin Y; Garcia A; Caballero A; Domínguez M; Martín Reyes M
    Schizophr Res; 2011 Aug; 130(1-3):293-4. PubMed ID: 21382695
    [No Abstract]   [Full Text] [Related]  

  • 22. Granulocytopenia with clozapine and quetiapine.
    Diaz P; Hogan TP
    Am J Psychiatry; 2001 Apr; 158(4):651. PubMed ID: 11282709
    [No Abstract]   [Full Text] [Related]  

  • 23. Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
    Meltzer HY
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):153-6. PubMed ID: 15780147
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone and clozapine for treatment-resistant schizophrenia.
    Dunayevich E; Chatterjee A
    Am J Psychiatry; 1999 Jul; 156(7):1127; author reply 1127-8. PubMed ID: 10401486
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood dehydroepiandrosterone sulfate as a prognostic index of treatment efficacy in residual schizophrenia].
    Ivanova SA; Fedorenko OIu; Semke AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):49-51. PubMed ID: 21329014
    [No Abstract]   [Full Text] [Related]  

  • 26. Weight loss and anorexia with quetiapine.
    Khawaja IS; Azeem MW; Ebrahim A
    Psychiatr Serv; 2005 Apr; 56(4):490. PubMed ID: 15812105
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
    Hayden F
    J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia, VI: Treatments.
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
    [No Abstract]   [Full Text] [Related]  

  • 29. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients.
    Ribolsi M; Magni V; Rubino IA
    Drugs Today (Barc); 2010 Aug; 46(8):581-7. PubMed ID: 20830318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpreting the results of the CATIE study.
    Pandiani JA; Banks SM
    Psychiatr Serv; 2006 Jan; 57(1):140-1. PubMed ID: 16399981
    [No Abstract]   [Full Text] [Related]  

  • 31. The new antipsychotic compounds: is a clinical choice algorithm possible?
    Wirshing WC
    West J Med; 1998 Jul; 169(1):43-4. PubMed ID: 9682633
    [No Abstract]   [Full Text] [Related]  

  • 32. Tardive dyskinesia with quetiapine.
    Ghelber D; Belmaker RH
    Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P; Tallerico T
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Switching to quetiapine fumarate monotherapy for treatment-resistant schizophrenia: a report of five cases].
    Sánchez-Araña Moreno T; Ruiz-Doblado S; Elorza-Guisasola J; Valmisa-Gómez de Lara E
    Actas Esp Psiquiatr; 2011; 39(5):336-8. PubMed ID: 21953364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 36. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal quetiapine abuse.
    Pierre JM; Shnayder I; Wirshing DA; Wirshing WC
    Am J Psychiatry; 2004 Sep; 161(9):1718. PubMed ID: 15337673
    [No Abstract]   [Full Text] [Related]  

  • 38. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 39. Did CATIE influence antipsychotic use?
    Citrome L; Jaffe A; Martello D; Allingham B; Levine J
    Psychiatr Serv; 2008 May; 59(5):476. PubMed ID: 18451000
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.